Global Dermal Filler Injections 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02255758

Publication Date:

February 28, 2025

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Dermal Filler Injections market size is predicted to grow from US$ 5223 million in 2025 to US$ 11100 million in 2031; it is expected to grow at a CAGR of 13.4% from 2025 to 2031.
Dermal filler injections are cosmetic procedures that involve the injection of gel-like substances into the skin to restore volume, smooth out wrinkles, and enhance facial contours. These fillers are primarily used for non-surgical facial rejuvenation and are a popular option for individuals seeking temporary results without the need for invasive surgery.
The global dermal filler injections market has experienced significant growth over the past decade and is expected to continue expanding. Factors contributing to this growth include the increasing demand for non-surgical cosmetic procedures, advancements in filler technology, growing awareness about facial aesthetics, and the desire for facial rejuvenation among aging populations. The market for dermal filler injections is global, with significant demand observed across various regions, including North America, Europe, Asia-Pacific, and other parts of the world. North America has traditionally held a prominent market share, driven by factors such as a large consumer base, advanced healthcare infrastructure, and high disposable incomes. However, the Asia-Pacific region, particularly China and South Korea, has been experiencing rapid growth due to increasing aesthetic consciousness and a growing middle-class population.
The 鈥淒ermal Filler Injections Industry Forecast鈥� looks at past sales and reviews total world Dermal Filler Injections sales in 2024, providing a comprehensive analysis by region and market sector of projected Dermal Filler Injections sales for 2025 through 2031. With Dermal Filler Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dermal Filler Injections industry.
This Insight Report provides a comprehensive analysis of the global Dermal Filler Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dermal Filler Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Dermal Filler Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dermal Filler Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dermal Filler Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Filler Injections market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hyaluronic Acid (HA)
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Polymethylmethacrylate (PMMA)
Segmentation by Application:
Hospital
Beauty Parlour
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Allergan
Galderma
LG Life Sciences
Hugel
Medytox
Merz
Sinclair Pharma
Suneva Medical
Luminera
Teoxane
Bausch Health
Humedix
Sanofi
Croma-Pharma GmbH
BLOOMAGE BIOTECH
Anika Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Dermal Filler Injections 麻豆原创 Size (2020-2031)
2.1.2 Dermal Filler Injections 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Dermal Filler Injections by Country/Region (2020, 2024 & 2031)
2.2 Dermal Filler Injections Segment by Type
2.2.1 Hyaluronic Acid (HA)
2.2.2 Calcium Hydroxylapatite (CaHA)
2.2.3 Poly-L-Lactic Acid (PLLA)
2.2.4 Polymethylmethacrylate (PMMA)
2.3 Dermal Filler Injections 麻豆原创 Size by Type
2.3.1 Dermal Filler Injections 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Dermal Filler Injections 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Dermal Filler Injections Segment by Application
2.4.1 Hospital
2.4.2 Beauty Parlour
2.4.3 Others
2.5 Dermal Filler Injections 麻豆原创 Size by Application
2.5.1 Dermal Filler Injections 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Dermal Filler Injections 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Dermal Filler Injections 麻豆原创 Size by Player
3.1 Dermal Filler Injections 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Dermal Filler Injections Revenue by Player (2020-2025)
3.1.2 Global Dermal Filler Injections Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Dermal Filler Injections Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dermal Filler Injections by Region
4.1 Dermal Filler Injections 麻豆原创 Size by Region (2020-2025)
4.2 Global Dermal Filler Injections Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dermal Filler Injections 麻豆原创 Size Growth (2020-2025)
4.4 APAC Dermal Filler Injections 麻豆原创 Size Growth (2020-2025)
4.5 Europe Dermal Filler Injections 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Dermal Filler Injections 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Dermal Filler Injections 麻豆原创 Size by Country (2020-2025)
5.2 Americas Dermal Filler Injections 麻豆原创 Size by Type (2020-2025)
5.3 Americas Dermal Filler Injections 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermal Filler Injections 麻豆原创 Size by Region (2020-2025)
6.2 APAC Dermal Filler Injections 麻豆原创 Size by Type (2020-2025)
6.3 APAC Dermal Filler Injections 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dermal Filler Injections 麻豆原创 Size by Country (2020-2025)
7.2 Europe Dermal Filler Injections 麻豆原创 Size by Type (2020-2025)
7.3 Europe Dermal Filler Injections 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermal Filler Injections by Region (2020-2025)
8.2 Middle East & Africa Dermal Filler Injections 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Dermal Filler Injections 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Dermal Filler Injections 麻豆原创 Forecast
10.1 Global Dermal Filler Injections Forecast by Region (2026-2031)
10.1.1 Global Dermal Filler Injections Forecast by Region (2026-2031)
10.1.2 Americas Dermal Filler Injections Forecast
10.1.3 APAC Dermal Filler Injections Forecast
10.1.4 Europe Dermal Filler Injections Forecast
10.1.5 Middle East & Africa Dermal Filler Injections Forecast
10.2 Americas Dermal Filler Injections Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Dermal Filler Injections Forecast
10.2.2 Canada 麻豆原创 Dermal Filler Injections Forecast
10.2.3 Mexico 麻豆原创 Dermal Filler Injections Forecast
10.2.4 Brazil 麻豆原创 Dermal Filler Injections Forecast
10.3 APAC Dermal Filler Injections Forecast by Region (2026-2031)
10.3.1 China Dermal Filler Injections 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Dermal Filler Injections Forecast
10.3.3 Korea 麻豆原创 Dermal Filler Injections Forecast
10.3.4 Southeast Asia 麻豆原创 Dermal Filler Injections Forecast
10.3.5 India 麻豆原创 Dermal Filler Injections Forecast
10.3.6 Australia 麻豆原创 Dermal Filler Injections Forecast
10.4 Europe Dermal Filler Injections Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Dermal Filler Injections Forecast
10.4.2 France 麻豆原创 Dermal Filler Injections Forecast
10.4.3 UK 麻豆原创 Dermal Filler Injections Forecast
10.4.4 Italy 麻豆原创 Dermal Filler Injections Forecast
10.4.5 Russia 麻豆原创 Dermal Filler Injections Forecast
10.5 Middle East & Africa Dermal Filler Injections Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Dermal Filler Injections Forecast
10.5.2 South Africa 麻豆原创 Dermal Filler Injections Forecast
10.5.3 Israel 麻豆原创 Dermal Filler Injections Forecast
10.5.4 Turkey 麻豆原创 Dermal Filler Injections Forecast
10.6 Global Dermal Filler Injections Forecast by Type (2026-2031)
10.7 Global Dermal Filler Injections Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Dermal Filler Injections Forecast
11 Key Players Analysis
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Dermal Filler Injections Product Offered
11.1.3 Allergan Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Galderma
11.2.1 Galderma Company Information
11.2.2 Galderma Dermal Filler Injections Product Offered
11.2.3 Galderma Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Galderma Main Business Overview
11.2.5 Galderma Latest Developments
11.3 LG Life Sciences
11.3.1 LG Life Sciences Company Information
11.3.2 LG Life Sciences Dermal Filler Injections Product Offered
11.3.3 LG Life Sciences Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 LG Life Sciences Main Business Overview
11.3.5 LG Life Sciences Latest Developments
11.4 Hugel
11.4.1 Hugel Company Information
11.4.2 Hugel Dermal Filler Injections Product Offered
11.4.3 Hugel Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Hugel Main Business Overview
11.4.5 Hugel Latest Developments
11.5 Medytox
11.5.1 Medytox Company Information
11.5.2 Medytox Dermal Filler Injections Product Offered
11.5.3 Medytox Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Medytox Main Business Overview
11.5.5 Medytox Latest Developments
11.6 Merz
11.6.1 Merz Company Information
11.6.2 Merz Dermal Filler Injections Product Offered
11.6.3 Merz Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Merz Main Business Overview
11.6.5 Merz Latest Developments
11.7 Sinclair Pharma
11.7.1 Sinclair Pharma Company Information
11.7.2 Sinclair Pharma Dermal Filler Injections Product Offered
11.7.3 Sinclair Pharma Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Sinclair Pharma Main Business Overview
11.7.5 Sinclair Pharma Latest Developments
11.8 Suneva Medical
11.8.1 Suneva Medical Company Information
11.8.2 Suneva Medical Dermal Filler Injections Product Offered
11.8.3 Suneva Medical Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Suneva Medical Main Business Overview
11.8.5 Suneva Medical Latest Developments
11.9 Luminera
11.9.1 Luminera Company Information
11.9.2 Luminera Dermal Filler Injections Product Offered
11.9.3 Luminera Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Luminera Main Business Overview
11.9.5 Luminera Latest Developments
11.10 Teoxane
11.10.1 Teoxane Company Information
11.10.2 Teoxane Dermal Filler Injections Product Offered
11.10.3 Teoxane Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Teoxane Main Business Overview
11.10.5 Teoxane Latest Developments
11.11 Bausch Health
11.11.1 Bausch Health Company Information
11.11.2 Bausch Health Dermal Filler Injections Product Offered
11.11.3 Bausch Health Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Bausch Health Main Business Overview
11.11.5 Bausch Health Latest Developments
11.12 Humedix
11.12.1 Humedix Company Information
11.12.2 Humedix Dermal Filler Injections Product Offered
11.12.3 Humedix Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Humedix Main Business Overview
11.12.5 Humedix Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Dermal Filler Injections Product Offered
11.13.3 Sanofi Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
11.14 Croma-Pharma GmbH
11.14.1 Croma-Pharma GmbH Company Information
11.14.2 Croma-Pharma GmbH Dermal Filler Injections Product Offered
11.14.3 Croma-Pharma GmbH Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Croma-Pharma GmbH Main Business Overview
11.14.5 Croma-Pharma GmbH Latest Developments
11.15 BLOOMAGE BIOTECH
11.15.1 BLOOMAGE BIOTECH Company Information
11.15.2 BLOOMAGE BIOTECH Dermal Filler Injections Product Offered
11.15.3 BLOOMAGE BIOTECH Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 BLOOMAGE BIOTECH Main Business Overview
11.15.5 BLOOMAGE BIOTECH Latest Developments
11.16 Anika Therapeutics
11.16.1 Anika Therapeutics Company Information
11.16.2 Anika Therapeutics Dermal Filler Injections Product Offered
11.16.3 Anika Therapeutics Dermal Filler Injections Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Anika Therapeutics Main Business Overview
11.16.5 Anika Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.